Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple Myeloma
Précis Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies …